ANNE KIBOCHO: Open Payments
NPI 1588309207 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 11 payments from 6 companies in 2025. Trend: 2023 $98 · 2024 $142 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $101 |
| Neurocrine BioSciences, Inc. | 1 | $99 |
| Janssen Pharmaceuticals, Inc | 2 | $81 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, Qelbree, LYBALVI, ABILIFY MAINTENA, REXULTI, ARISTADA.
Industry payments across MD — which companies pay providers there.
